Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Coco

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Cells|February 25, 2023
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 ModulationDelfina Costa, Roberta Venè, Simona Coco, et al.
BMC Cancer|December 17, 2009
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastomaPaola Scaruffi, Sara Stigliani, Stefano Moretti, et al.
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
Critical Reviews in Clinical Laboratory Sciences|May 26, 2025
New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical toolSara Santamaria, Barbara Cardinali, Matteo Rovere, et al.
Cancer|August 2, 2008
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theoryDomenico Albino, Paola Scaruffi, Stefano Moretti, et al.
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.
Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Cells|February 25, 2023
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 ModulationDelfina Costa, Roberta Venè, Simona Coco, et al.
BMC Cancer|December 17, 2009
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastomaPaola Scaruffi, Sara Stigliani, Stefano Moretti, et al.
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
Critical Reviews in Clinical Laboratory Sciences|May 26, 2025
New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical toolSara Santamaria, Barbara Cardinali, Matteo Rovere, et al.
Cancer|August 2, 2008
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theoryDomenico Albino, Paola Scaruffi, Stefano Moretti, et al.
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.
Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Pageof 10